{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:58:52Z","timestamp":1791928732217,"version":"4.3.4"},"reference-count":53,"publisher":"Association for Research in Vision and Ophthalmology (ARVO)","issue":"14","license":[{"start":{"date-parts":[[2020,12,15]],"date-time":"2020-12-15T00:00:00Z","timestamp":1607990400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Invest. Ophthalmol. Vis. Sci."],"published-print":{"date-parts":[[2020,12,15]]},"DOI":"10.1167\/iovs.61.14.15","type":"journal-article","created":{"date-parts":[[2020,12,15]],"date-time":"2020-12-15T12:29:23Z","timestamp":1608035363000},"page":"15","source":"Crossref","is-referenced-by-count":48,"title":["Effects of Atropine Treatment on Choroidal Thickness in Myopic Children"],"prefix":"10.1167","volume":"61","author":[{"given":"Luyao","family":"Ye","sequence":"first","affiliation":[{"name":"Shanghai Eye Disease Prevention and Treatment Center, Shanghai Eye Hospital, Shanghai, China"},{"name":"Department of Ophthalmology, Shanghai General Hospital, Shanghai Jiao Tong University, National Clinical Research Center for Eye Diseases, Shanghai Key Laboratory of Ocular Fundus Diseases, Shanghai Engineering Center for Visual Science and Photomedicine, Shanghai Engineering Center for Precise Diagnosis and Treatment of Eye Diseases, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya","family":"Shi","sequence":"additional","affiliation":[{"name":"Shanghai Eye Disease Prevention and Treatment Center, Shanghai Eye Hospital, Shanghai, China"},{"name":"Department of Ophthalmology, Shanghai General Hospital, Shanghai Jiao Tong University, National Clinical Research Center for Eye Diseases, Shanghai Key Laboratory of Ocular Fundus Diseases, Shanghai Engineering Center for Visual Science and Photomedicine, Shanghai Engineering Center for Precise Diagnosis and Treatment of Eye Diseases, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Yin","sequence":"additional","affiliation":[{"name":"Shanghai Eye Disease Prevention and Treatment Center, Shanghai Eye Hospital, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanshan","family":"Li","sequence":"additional","affiliation":[{"name":"Shanghai Eye Disease Prevention and Treatment Center, Shanghai Eye Hospital, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangnan","family":"He","sequence":"additional","affiliation":[{"name":"Shanghai Eye Disease Prevention and Treatment Center, Shanghai Eye Hospital, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianfeng","family":"Zhu","sequence":"additional","affiliation":[{"name":"Shanghai Eye Disease Prevention and Treatment Center, Shanghai Eye Hospital, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xun","family":"Xu","sequence":"additional","affiliation":[{"name":"Shanghai Eye Disease Prevention and Treatment Center, Shanghai Eye Hospital, Shanghai, China"},{"name":"Department of Ophthalmology, Shanghai General Hospital, Shanghai Jiao Tong University, National Clinical Research Center for Eye Diseases, Shanghai Key Laboratory of Ocular Fundus Diseases, Shanghai Engineering Center for Visual Science and Photomedicine, Shanghai Engineering Center for Precise Diagnosis and Treatment of Eye Diseases, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"27","reference":[{"key":"bib1","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1038\/519276a","article-title":"The myopia boom","volume":"519","author":"Dolgin","year":"2015","journal-title":"Nature"},{"key":"bib2","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/j.ophtha.2016.01.006","article-title":"Global prevalence of myopia and high myopia and temporal trends from 2000 through 2050","volume":"123","author":"Holden","year":"2016","journal-title":"Ophthalmology"},{"key":"bib3","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1136\/bjophthalmol-2017-311266","article-title":"Global prevalence of visual impairment associated with myopic macular degeneration and temporal trends from 2000 through 2050: systematic review, meta-analysis and modelling","volume":"102","author":"Fricke","year":"2018","journal-title":"Br J Ophthalmol"},{"key":"bib4","doi-asserted-by":"publisher","first-page":"4603","DOI":"10.1167\/iovs.18-24032","article-title":"Prevalence, risk factors, and impact of myopic macular degeneration on visual impairment and functioning among adults in Singapore","volume":"59","author":"Wong","year":"2018","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib5","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1016\/j.ophtha.2006.05.062","article-title":"Atropine for the treatment of childhood myopia","volume":"113","author":"Chua","year":"2006","journal-title":"Ophthalmology"},{"key":"bib6","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.jaapos.2015.04.006","article-title":"Therapeutic effect of atropine 1% in children with low myopia","volume":"19","author":"Yi","year":"2015","journal-title":"J AAPOS"},{"key":"bib7","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s10384-006-0380-7","article-title":"Topical atropine in retarding myopic progression and axial length growth in children with moderate to severe myopia: a pilot study","volume":"51","author":"Fan","year":"2007","journal-title":"Jpn J Ophthalmol"},{"key":"bib8","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.ophtha.2015.11.010","article-title":"Efficacy comparison of 16 interventions for myopia control in children: a network meta-analysis","volume":"123","author":"Huang","year":"2016","journal-title":"Ophthalmology"},{"key":"bib9","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.ophtha.2008.10.020","article-title":"Atropine for the treatment of childhood myopia: effect on myopia progression after cessation of atropine","volume":"116","author":"Tong","year":"2009","journal-title":"Ophthalmology"},{"key":"bib10","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1001\/jamaophthalmol.2017.1091","article-title":"Efficacy and adverse effects of atropine in childhood myopia: a meta-analysis","volume":"135","author":"Gong","year":"2017","journal-title":"JAMA Ophthalmol"},{"key":"bib11","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.ophtha.2011.07.031","article-title":"Atropine for the treatment of childhood myopia: safety and efficacy of 0.5%, 0.1%, and 0.01% doses (Atropine for the Treatment of Myopia 2)","volume":"119","author":"Chia","year":"2012","journal-title":"Ophthalmology"},{"key":"bib12","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.ajo.2013.09.020","article-title":"Atropine for the treatment of childhood myopia: changes after stopping atropine 0.01%, 0.1% and 0.5%","volume":"157","author":"Chia","year":"2014","journal-title":"Am J Ophthalmol"},{"key":"bib13","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.ophtha.2018.05.029","article-title":"Low-Concentration Atropine for Myopia Progression (LAMP) Study: a randomized, double-blinded, placebo-controlled trial of 0.05%, 0.025%, and 0.01% atropine eye drops in myopia control","volume":"126","author":"Yam","year":"2019","journal-title":"Ophthalmology"},{"key":"bib14","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1001\/jamaophthalmol.2020.3820","article-title":"Safety and efficacy of low-dose atropine eyedrops for the treatment of myopia progression in Chinese children: a randomized clinical trial","volume":"138","author":"Wei","year":"2020","journal-title":"JAMA Ophthalmol"},{"key":"bib15","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1007\/s10792-020-01356-x","article-title":"Part-time use of 1% atropine eye drops for prevention of myopia progression in children","volume":"40","author":"Foo","year":"2020","journal-title":"Int Ophthalmol"},{"key":"bib16","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.1016\/j.ophtha.2003.12.007","article-title":"A randomized trial of atropine regimens for treatment of moderate amblyopia in children","volume":"111","author":"Repka","year":"2004","journal-title":"Ophthalmology"},{"key":"bib17","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1001\/archophthalmol.2008.107","article-title":"Patching vs atropine to treat amblyopia in children aged 7 to 12 years: a randomized trial","volume":"126","author":"Scheiman","year":"2008","journal-title":"Arch Ophthalmol"},{"key":"bib18","doi-asserted-by":"publisher","first-page":"E7091","DOI":"10.1073\/pnas.1721443115","article-title":"Scleral hypoxia is a target for myopia control","volume":"115","author":"Wu","year":"2018","journal-title":"Proc Natl Acad Sci USA"},{"key":"bib19","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.preteyeres.2009.12.002","article-title":"The multifunctional choroid","volume":"29","author":"Nickla","year":"2010","journal-title":"Prog Retin Eye Res"},{"key":"bib20","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1006\/exer.1999.0813","article-title":"Choroidal retinoic acid synthesis: a possible mediator between refractive error and compensatory eye growth","volume":"70","author":"Mertz","year":"2000","journal-title":"Exp Eye Res"},{"key":"bib21","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1076\/ceyr.22.2.121.5525","article-title":"Identification of choroidal ovotransferrin as a potential ocular growth regulator","volume":"22","author":"Rada","year":"2001","journal-title":"Curr Eye Res"},{"key":"bib22","first-page":"588","article-title":"Early transcriptional changes of retinal and choroidal TGFbeta-2, RALDH-2, and ZENK following imposed positive and negative defocus in chickens","volume":"10","author":"Simon","year":"2004","journal-title":"Mol Vis"},{"key":"bib23","first-page":"1259","article-title":"Vision-dependent changes in the choroidal thickness of macaque monkeys","volume":"41","author":"Hung","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib24","doi-asserted-by":"publisher","first-page":"6262","DOI":"10.1167\/iovs.10-5457","article-title":"Human optical axial length and defocus","volume":"51","author":"Read","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib25","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.ajo.2020.01.003","article-title":"Changes in choroidal thickness varied by age and refraction in children and adolescents: a 1-year longitudinal study","volume":"213","author":"Xiong","year":"2020","journal-title":"Am J Ophthalmol"},{"key":"bib26","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.clae.2017.09.010","article-title":"Choroidal thickness and axial length changes in myopic children treated with orthokeratology","volume":"40","author":"Li","year":"2017","journal-title":"Cont Lens Anterior Eye"},{"key":"bib27","doi-asserted-by":"publisher","first-page":"e454","DOI":"10.1111\/aos.2019.97.issue-3","article-title":"Change in subfoveal choroidal thickness secondary to orthokeratology and its cessation: a predictor for the change in axial length","volume":"97","author":"Li","year":"2019","journal-title":"Acta Ophthalmol"},{"key":"bib28","doi-asserted-by":"publisher","first-page":"34936","DOI":"10.1038\/srep34936","article-title":"The effect of topical atropine on the choroidal thickness of healthy children","volume":"6","author":"Zhang","year":"2016","journal-title":"Sci Rep"},{"key":"bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.clae.2020.06.006","article-title":"Short-term effects of atropine combined with orthokeratology (ACO) on choroidal thickness","author":"Zhao","year":"2020 Jun 30","journal-title":"Cont Lens Anterior Eye"},{"key":"bib30","doi-asserted-by":"crossref","DOI":"10.1111\/cxo.13128","article-title":"Comparisons of atropine versus cyclopentolate cycloplegia in myopic children","author":"Ye","year":"2020 Aug 25","journal-title":"Clinical and Experimental Optometry"},{"key":"bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.jfo.2020.04.023","article-title":"Effect of 0.01% atropine eye drops on choroidal thickness in myopic children","author":"Li","year":"2020 Aug 19","journal-title":"J Fr Ophtalmol"},{"key":"bib32","doi-asserted-by":"publisher","first-page":"5176","DOI":"10.1167\/iovs.18-25389","article-title":"Ocular biometric diurnal rhythms in emmetropic and myopic adults","volume":"59","author":"Burfield","year":"2018","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib33","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1056\/NEJMra050100","article-title":"Adherence to medication","volume":"353","author":"Osterberg","year":"2005","journal-title":"N Engl J Med"},{"key":"bib34","doi-asserted-by":"publisher","first-page":"304","DOI":"10.4065\/mcp.2010.0575","article-title":"Medication adherence: WHO cares?","volume":"86","author":"Brown","year":"2011","journal-title":"Mayo Clin Proc"},{"key":"bib35","first-page":"116","article-title":"Generalized estimating equations (GEE) to handle missing data and time-dependent variables in longitudinal studies: an application to assess the evolution of health related quality of life in coronary patients","volume":"40","author":"Duenas","year":"2016","journal-title":"Epidemiol Prev"},{"key":"bib36","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.exer.2006.01.029","article-title":"Inhibiting the transient choroidal thickening response using the nitric oxide synthase inhibitor L-NAME prevents the ameliorative effects of visual experience on ocular growth in two different visual paradigms","volume":"83","author":"Nickla","year":"2006","journal-title":"Exp Eye Res"},{"key":"bib37","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1097\/00006324-200402000-00009","article-title":"The effect of the nonspecific nitric oxide synthase inhibitor NG-nitro-L-arginine methyl ester on the choroidal compensatory response to myopic defocus in chickens","volume":"81","author":"Nickla","year":"2004","journal-title":"Optom Vis Sci"},{"key":"bib38","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41598-016-0002-7","article-title":"Nitric oxide (NO) mediates the inhibition of form-deprivation myopia by atropine in chicks","volume":"6","author":"Carr","year":"2016","journal-title":"Sci Rep"},{"key":"bib39","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1017\/S0952523800171184","article-title":"Effects of atropine on refractive development, dopamine release, and slow retinal potentials in the chick","volume":"17","author":"Schwahn","year":"2000","journal-title":"Vis Neurosci"},{"key":"bib40","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/j.exer.2010.08.021","article-title":"Dopaminergic agonists that result in ocular growth inhibition also elicit transient increases in choroidal thickness in chicks","volume":"91","author":"Nickla","year":"2010","journal-title":"Exp Eye Res"},{"key":"bib41","doi-asserted-by":"publisher","first-page":"6414","DOI":"10.1167\/iovs.15-17102","article-title":"Regional changes in choroidal thickness associated with accommodation","volume":"56","author":"Woodman-Pieterse","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib42","doi-asserted-by":"publisher","first-page":"5049","DOI":"10.1167\/iovs.12-10847","article-title":"Accommodative movements of the vitreous membrane, choroid, and sclera in young and presbyopic human and nonhuman primate eyes","volume":"54","author":"Croft","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib43","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1097\/OPX.0b013e3182640996","article-title":"Myopia progression in Chinese children is slower in summer than in winter","volume":"89","author":"Donovan","year":"2012","journal-title":"Optometry Vision Sci"},{"key":"bib44","doi-asserted-by":"publisher","first-page":"3074","DOI":"10.1167\/iovs.18-26397","article-title":"Changes in choroidal thickness and choroidal blood perfusion in guinea pig myopia","volume":"60","author":"Zhang","year":"2019","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib45","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1167\/iovs.61.4.18","article-title":"Features of the choroidal structures in myopic children based on image binarization of optical coherence tomography","volume":"61","author":"Li","year":"2020","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib46","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.ajo.2017.02.001","article-title":"Characterization of choroidal morphologic and vascular features in young men with high myopia using spectral-domain optical coherence tomography","volume":"177","author":"Gupta","year":"2017","journal-title":"Am J Ophthalmol"},{"key":"bib47","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.ajo.2015.01.029","article-title":"Risk factors for progressive myopia in the atropine therapy for myopia study","volume":"159","author":"Loh","year":"2015","journal-title":"Am J Ophthalmol"},{"key":"bib48","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1089\/jop.2011.0027","article-title":"The long-term results of using low-concentration atropine eye drops for controlling myopia progression in schoolchildren","volume":"27","author":"Wu","year":"2011","journal-title":"J Ocul Pharmacol Ther"},{"key":"bib49","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1167\/iovs.15-18263","article-title":"Parapapillary gamma zone and axial elongation-associated optic disc rotation: the Beijing Eye Study","volume":"57","author":"Jonas","year":"2016","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib50","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/j.ophtha.2017.12.005","article-title":"Progression of myopic maculopathy during 18-year follow-up","volume":"125","author":"Fang","year":"2018","journal-title":"Ophthalmology"},{"key":"bib51","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1016\/j.ophtha.2018.01.035","article-title":"Ten-year progression of myopic maculopathy: the Beijing Eye Study 2001-2011","volume":"125","author":"Yan","year":"2018","journal-title":"Ophthalmology"},{"key":"bib52","doi-asserted-by":"publisher","first-page":"176","DOI":"10.7150\/ijms.39365","article-title":"Efficacy and safety of 1% atropine on retardation of moderate myopia progression in Chinese school children","volume":"17","author":"Zhu","year":"2020","journal-title":"Int J Med Sci"},{"key":"bib53","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1111\/aos.2019.97.issue-5","article-title":"Risk factors for high myopia: a 22-year follow-up study from childhood to adulthood","volume":"97","author":"Parssinen","year":"2019","journal-title":"Acta Ophthalmol"}],"container-title":["Investigative Opthalmology & Visual Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/iovs.arvojournals.org\/article.aspx?articleid=2772063","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:31:14Z","timestamp":1791927074000},"score":1,"resource":{"primary":{"URL":"https:\/\/iovs.arvojournals.org\/article.aspx?articleid=2772063"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,15]]},"references-count":53,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2020,12,1]]}},"URL":"https:\/\/doi.org\/10.1167\/iovs.61.14.15","relation":{},"ISSN":["1552-5783"],"issn-type":[{"value":"1552-5783","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12,15]]}}}